Biohaven Ltd. (NYSE:BHVN) Poised For Near-Term Upside As Regulatory Path Clarifies
![]() |
Momentum indicators and recent regulatory developments shift the near-term bias toward upside, while balance-sheet strength cushions ongoing operating losses. Fundamentals show meaningful liquidity and elevated leverage that frame the company’s valuation as under-valued by WMDST. |









